Publications and communications of Morgan VANDERMEULEN

Vandermeulen, M. (2023). Mesenchymal Stromal Cells in Liver Transplantation, Translational Investigations from a phase I-II Clinical Trial to a Rodent Model of Acute Graft Rejection [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/308176

Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada.

LAMBRECHT, C., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., AMICONE, C., Warling, O., Lamproye, A., Delwaide, J., MEURISSE, N., Honoré, P., Hustinx, R., Lovinfosse, P., & Detry, O. (March 2023). 18FDG PET scanner as a selection criterion in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 86 (1), 17.

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., JORIS, J., Delwaide, J., & Detry, O. (August 2022). Impact of donor age over 70 years in donation after circulatory death liver transplantation: a 15 years of experience. Transplantation, 106 (8S), 73 (LB-O-15.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., Joris, J., Delwaide, J., & Detry, O. (05 May 2022). IMPACT OF DONOR AGE OVER 70 YEARS IN DONATION AFTER CIRCULATORY DEATH LIVER TRANSPLANTATION : A 15 YEARS OF EXPERIENCE [Paper presentation]. Belgian Surgical Week 2022, Ostende, Belgium.

VANDERMEULEN, M., Verscheure, D., & Genser, L. (February 2022). Aorto-duodenal fistula secondary to aortic graft replacement. Acta Chirurgica Belgica, 122 (1), 74-75. doi:10.1080/00015458.2021.2021719

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323

Malisoux, C., KOCH, J.-N., MEURISSE, N., Lagny, M., VANDERMEULEN, M., HONORE, P., JOURET, F., DELANAYE, P., & DETRY, O. (August 2021). Perioperative risk factors of acute kidney injury post liver transplantation: a monocentric retrospective cohort study of 260 patients. Transplant International, 34 (S1 POS315), 312.

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101.

VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45.

Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium.

Schielke, A. A., Paolucci, M., MEURISSE, N., Vandermeulen, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (October 2019). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS. Transplant International, 32 (S2), 029 p165.

Schielke, A. A., Paolucci, M., MEURISSE, N., VANDERMEULEN, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (29 November 2018). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS [Paper presentation]. 14eme Congrès Francophone de Chirurgie Digestive et Hépato-Bilio-Pancréatique, Marne la Vallée, France.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (15 March 2018). Liver transplantation in Jehovah’s Witnesses: a single center-experience [Paper presentation]. Joint NTV-BTS Transplantation congress, Rotterdam, Netherlands.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (January 2018). Liver transplantation in Jehovah's witnesses. Acta Gastro-Enterologica Belgica, 81 (1), 30.

MEURISSE, N., Smet, H., LEDOUX, D., VANDERMEULEN, M., GOREUX, J.-P., KABA, A., JORIS, J., HONORE, P., & DETRY, O. (September 2017). Surgical factors and not donor type per se are risk factors for acute kidney injury after liver transplantation. Transplant International, 30 (S2), 106-107 (OS298.

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12.

VANDERMEULEN, M., & DETRY, O. (07 December 2015). Laparoscopic management of a traumatic lumbar hernia: about a case [Paper presentation]. Cases "à la carte", Brussels, Belgium.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052.

Detry, O., Govaerts, L., De Roover, A., VANDERMEULEN, M., MEURISSE, N., Malenga, BLETARD, N., Mbendi, C., LAMPROYE, A., Honoré, P., MEUNIER, P., Delwaide, J., & Hustinx, R. (14 March 2015). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World Journal of Gastroenterology, 21 (10), 3049-54. doi:10.3748/wjg.v21.i10.3049

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29.

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

MEURISSE, N., DETRY, O., Govaerts, L., DE ROOVER, A., VANDERMEULEN, M., Malenga, S., BLETARD, N., Mbendi, C., LAMPROYE, A., HONORE, P., MEUNIER, P., Delwaide, J., & HUSTINX, R. (September 2014). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. Transplant International, 27 (S2), 18 (EP-17.

VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418